Table: Phoenixbio - 9-MTH group results

PhoenixBio

13/02/2026 06:44

Feb 13 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.20                1.14             1.64     
                 (+5.0 pct)          (-13.9 pct)      (+6.4 pct)  
  Operating        68 mln           loss 153 mln        109 mln   
  Recurring        98 mln           loss 146 mln        116 mln   
  Net              93 mln           loss 150 mln        110 mln   
  EPS             22.94 yen        loss 37.29 yen      27.13 yen  
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T